Liquid Biopsy: CTC, CTDNA, Exosome etc.

Clinical Utility of Multigene Assays in Breast Cancer

Artificial Intelligence in Treatment of Breast Cancer Patients: Need of the Day: Role of AI Watson for Oncology

Can We Omit Surgery with Suggestion of pCR by Biopsy in the Breast?

Evaluation of Axillary LNs after Neoadjuvant Systemic Therapy

Evaluation of Pathologic Response in Breast Cancer Treated with Primary Systemic Therapy

Radiation Therapy for Patients with pCR after Neoadjuvant Chemotherapy

New Techniques and Technology in Breast Screening Including Contrast Enhanced Mammography

Automated Breast US as Supplemental Screening Modality in Women with Dense Breasts

Abbreviated Breast MRI for High-risk Breast Cancer Screening

DEAD-BOX RNA HELICASE DP103 ENHANCES YAP SUMOYLATION FOR YAP-TEAD DEPENDENCE AND STATIN SENSITIVITY IN TRIPLE NEGATIVE BREAST CANCER

RESVERATROL SUPPRESSES BREAST CANCER PROLIFERATION THROUGH INHIBITION OF STAT3 ACTIVATION AND M2-MACROPHAGE POLARIZATION

ESTROGEN RECEPTOR POSITIVE IS NOT ENOUGH TO PREDICT THE PROGNOSIS OF BREAST CANCER

CLINICOPATHOLOGICAL FACTORS AFFECTING DISTANT METASTASIS IN LOCOREGIONAL RECURRENCE OF BREAST CANCER

ULTRASOUND-GUIDED RESTAGING AND LOCALIZATION OF AXILLARY LYMPH NODES AFTER NEOADJUVANT CHEMOTHERAPY FOR GUIDANCE OF AXILLARY SURGERY IN BREAST CANCER PATIENTS: EXPERIENCE WITH ACTIVATED CHARCOAL

APPLICATION OF ROBOTIC SURGERY (DA VINCI) IN THE MANAGEMENT OF BREAST CANCER- PRELIMINARY RESULTS AND EXPERIENCE SHARING

CHARACTERIZATION OF THE MICROBIOME OF BREAST TISSUE AND GUT IN KOREAN BREAST CANCER PATIENTS

PREDICTING THE RISK OF PERIPHERAL NEUROPATHY BY THE COMBINATION OF FOUR SERUM MICRORNAS

Overview of Therapeutic Strategies for Early Breast Cancer Patients: Past, Present and Future

Ethnic Differences in the Treatment Landscape of Breast Cancer: Western vs. Asian

Application of the Concept of Intrinsic Subtypes to Clinical Decision Making

Heterogeneity of HER2: Mutation, Amplification, Expression and Clinical Implications

Biomarkers for HER2-directed Therapies: Past Failure and Future Perspectives

Evolving Strategies to Overcome Resistance to HER2 Targeted Agents

How to Make a Good Mastectomy for Reconstruction Based on the Anatomy

Reconstruction with Autologous Tissue

Reconstruction with Implant

Addressing Relationships Following a Breast Cancer Diagnosis: The Impact on Partners, Children and Caregivers

The Effect of Exercise Recommendation on the Level of Physical Activity in Breast Cancer

Heart Disease in Breast Cancer Survivors

No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-conserving Surgery

Imaging Biomarker for Molecular Oncology: Focusing on HER2 Evaluation

A Phase II Trial of Pan-HER Inhibitor Poziotinib, in Patients with HER2-positive Metastatic Breast Cancer Who Have Received at Least Two Prior HER2 Therapies

Ribociclib Plus Goserelin and Tamoxifen or a Non-steroidal Aromatase Inhibitor (NSAI) for Premenopausal Women with Hormone Receptor-positive (HR+), Human Epidermal Growth Factor Receptor 2-negative (HER2–) Advanced Breast Cancer (ABC) in the Randomized Phase III MONALEESA-7 Trial

Different Prognosis of Young Breast Cancer Patients in Their 20s and 30s Depending on Subtype: A Nationwide Study from the Korean Breast Cancer Society

Know-how for How Asian Doctors Can Build a Career with a Global Perspective

Steps to Getting Your Manuscript Published in a High Quality Medical Journal

Current Approaches in Treatment of TNBC

PARP Inhibitors and DNA Repair

Novel Targets and Overview of Ongoing Clinical Trials

International Guidelines for the Use of NGS Panels

Biomarker Driven Cancer Therapy by Multiple NGS Panels for Somatic Mutations

Application of Multiple NGS Panels for Germline Variation to Real Practice

Appropriate Concept of Prevention of Lymphedema at the Initial Treatment

Early-stage Lymphedema Detection and Conservative Treatment

Surgical Treatment Options for Advanced Lymphedema

The Reality in the Follow-up of Breast Cancer Survivors

Comprehensive Analysis of National Health Insurance Data for Breast Cancer Survivorship

Benchmarking Breast Cancer Survival: International Collaborative Research Platform to Improve Patients Outcome